scholarly journals 1153TiP A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel cell carcinoma progressing on anti-PD-(L)1 antibody therapy: The MERKLIN 2 study

2020 ◽  
Vol 31 ◽  
pp. S767-S768
Author(s):  
A.C.J. van Akkooi ◽  
P.A. Ascierto ◽  
J.C. Becker ◽  
P. Nathan ◽  
P. Nghiem ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Phase Ii ◽  
Antibody Therapy ◽  
Merkel Cell ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A Phase II, Open-Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile Hemangioma

2009 ◽  
Vol 26 (2) ◽  
pp. 203-212 ◽  
Author(s):  
Catherine C. McCuaig ◽  
Josée Dubois ◽  
Julie Powell ◽  
Claude Belleville ◽  
Michèle David ◽  
...  
Keyword(s):  
Phase Ii ◽  
Infantile Hemangioma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma

2005 ◽  
Vol 57 (4) ◽  
pp. 533-539 ◽  
Author(s):  
Monika Jermann ◽  
Rolf A Stahel ◽  
Marc Salzberg ◽  
Thomas Cerny ◽  
Markus Joerger ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Locally Advanced ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in KRAS-Mutant Metastatic Colorectal Cancer

PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e62264 ◽  
Author(s):  
Salvatore Siena ◽  
Eric Van Cutsem ◽  
Mingyu Li ◽  
Ulf Jungnelius ◽  
Alfredo Romano ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Efficacy and safety of olaparib monotherapy in a subgroup of patients with a germline BRCA1/2 mutation and advanced ovarian cancer from a Phase II open-label study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 5529-5529 ◽  
Author(s):  
Susan M. Domchek ◽  
Ronnie Shapira-Frommer ◽  
Rita K. Schmutzler ◽  
M. William Audeh ◽  
Michael Friedlander ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Advanced Ovarian Cancer ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document